Greatbatch Inc  

(Public, NYSE:GB)   Watch this stock  
Find more results for GB
31.28
+0.27 (0.87%)
May 17 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 30.89 - 31.36
52 week 20.29 - 31.36
Open 31.13
Vol / Avg. 129,823.00/121,219.00
Mkt cap 743.06M
P/E     -
Div/yield     -
EPS -0.16
Shares 23.76M
Beta 0.70
Inst. own 96%
Jul 22, 2013
Q2 2013 Greatbatch, Inc. Earnings Release Add to calendar
May 16, 2013
Greatbatch, Inc. at Bank of America Merrill Lynch Health Care Conference
Apr 25, 2013
Q1 2013 Greatbatch, Inc. Earnings Conference Call - Webcast
Apr 25, 2013
Q1 2013 Greatbatch, Inc. Earnings Release
Mar 19, 2013
Greatbatch, Inc. at Sidoti Emerging Growth Institutional Investor Forum
Mar 18, 2013
Greatbatch, Inc. Investor Day - Webcast
Feb 27, 2013
Greatbatch, Inc. at RBC Capital Markets' Healthcare Conference - Webcast
Feb 25, 2013
Q4 2012 Greatbatch, Inc. Earnings Conference Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '13) 2012
Net profit margin 3.82% -0.74%
Operating margin 9.67% 4.00%
EBITD margin - 26.86%
Return on average assets 2.56% -0.54%
Return on average equity 4.68% -1.01%
Employees 3,310 -
Carbon Disclosure Rating - -

Address

Suite 310, 2595 North Dallas P
FRISCO, TX 75034
United States - Map
+1-716-7595600 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

Greatbatch, Inc. (Greatbatch) is developer and manufacturer of components for implantable medical devices (IMDs) and Electrochem batteries. The Company operates in two segments: Greatbatch Medical and Electrochem Solutions (Electrochem). The Company�s customers include large multi-national original equipment manufacturers (OEMs). The Greatbatch Medical segment designs and manufactures medical devices and components primarily for the cardiac rhythm management (CRM), neuromodulation, vascular access and orthopaedic markets. In addition, Greatbatch Medical offers assembly and design engineering services for products that incorporate Greatbatch Medical components. Electrochem segment provides technology solutions. On February 16, 2012, Greatbatch purchased NeuroNexus Technologies, Inc. (NeuroNexus). On December 15, 2011, Electrochem acquired Micro Power Electronics, Inc. (Micro Power).

Officers and directors

Bill R. Sanford Independent Chairman of the Board
Age: 68
Bio & Compensation  - Reuters
Thomas J. Hook President, Chief Executive Officer, Director
Age: 50
Bio & Compensation  - Reuters
Michael Dinkins Chief Financial Officer, Senior Vice President
Age: 58
Bio & Compensation  - Reuters
Mauricio Arellano President - Greatbatch Medical segment
Age: 46
Bio & Compensation  - Reuters
Susan M. Bratton President of Electrochem Solutions, Inc.
Age: 56
Bio & Compensation  - Reuters
Michelle Graham Senior Vice President - Human Resources
Age: 46
Bio & Compensation  - Reuters
Daniel R. Kaiser Ph.D. Vice President, Chief Technology Officer
Age: 43
Bio & Compensation  - Reuters
Timothy G. McEvoy Vice President, General Counsel, Secretary
Age: 55
Bio & Compensation  - Reuters
Joseph W. Dziedzic Director
Age: 44
Bio & Compensation  - Reuters
Rudy A. Mazzocchi Director
Bio & Compensation  - Reuters